De Iuliis A, Montinaro E, Fatati G, Plebani M, Colosimo C
Neural Regen Res. 2021; 17(3):523-533.
PMID: 34380882
PMC: 8504381.
DOI: 10.4103/1673-5374.320965.
Li M, Maddison L, Page-McCaw P, Chen W
Am J Physiol Endocrinol Metab. 2014; 306(7):E799-807.
PMID: 24473439
PMC: 3962607.
DOI: 10.1152/ajpendo.00686.2013.
Ustione A, Piston D, Harris P
Mol Endocrinol. 2013; 27(8):1198-207.
PMID: 23744894
PMC: 3725340.
DOI: 10.1210/me.2013-1083.
Ustione A, Piston D
Mol Endocrinol. 2012; 26(11):1928-40.
PMID: 22918877
PMC: 3487623.
DOI: 10.1210/me.2012-1226.
Raffo A, Hancock K, Polito T, Xie Y, Andan G, Witkowski P
J Endocrinol. 2008; 198(1):41-9.
PMID: 18577569
PMC: 2712213.
DOI: 10.1677/JOE-07-0632.
VMAT2 gene expression and function as it applies to imaging beta-cell mass.
Harris P, Ferrara C, Barba P, Polito T, Freeby M, Maffei A
J Mol Med (Berl). 2007; 86(1):5-16.
PMID: 17665159
DOI: 10.1007/s00109-007-0242-x.
Metabolic consequences of atypical antipsychotic drugs.
Lebovitz H
Psychiatr Q. 2003; 74(3):277-90.
PMID: 12918602
DOI: 10.1023/a:1024170622266.
Neuroendocrine control of basal insulin secretion in man: a study with bromocriptine, clonidine and naloxone.
ZAMPA G, Benfenati F, Ghisoli E, Corbucci G, VECCHI P, Zini I
J Endocrinol Invest. 1981; 4(4):423-9.
PMID: 7037921
DOI: 10.1007/BF03348306.
Further studies on 5-hydroxytryptamine transport in pancreatic islets and isolated beta-cells.
Lindstrom P
Br J Pharmacol. 1981; 73(2):385-91.
PMID: 7016232
PMC: 2071649.
DOI: 10.1111/j.1476-5381.1981.tb10433.x.
Further studies on the effects of 5-hydroxytryptophan on plasma glucose and insulin in the mouse.
Furman B, Wilson G
Diabetologia. 1980; 19(4):386-90.
PMID: 7000601
DOI: 10.1007/BF00280525.
Characteristics of 5-hydroxytryptamine transport in pancreatic islets.
Lindstrom P, Sehlin J, Taljedal I
Br J Pharmacol. 1980; 68(4):773-8.
PMID: 6991048
PMC: 2044246.
DOI: 10.1111/j.1476-5381.1980.tb10871.x.
Therapy of malignant hamster insulinomas with monoamine precursors.
Feldman J, Vervaert C, Klatt C, Seigler H
Diabetologia. 1981; 20(2):148-54.
PMID: 6259010
DOI: 10.1007/BF00262019.
Islet cell interactions with pancreatic B-cells.
Pipeleers D
Experientia. 1984; 40(10):1114-26.
PMID: 6149149
DOI: 10.1007/BF01971459.
Improved oral glucose tolerance following antiserotonin treatment in patients with chemical diabetes.
Ferrari C, Barbieri C, Caldara R, Magnoni V, Testori G, ROMUSSI M
Eur J Clin Pharmacol. 1979; 15(6):395-9.
PMID: 499287
DOI: 10.1007/BF00561737.
Accumulation of dopamine in mouse pancreatic B-cells following injection of L-DOPA. Localization to secretory granules and inhibition of insulin secretion.
Ericson L, Hakanson R, Lundquist I
Diabetologia. 1977; 13(2):117-24.
PMID: 404204
DOI: 10.1007/BF00745138.
Intracellular pancreatic B cell serotonin and the dynamics of insulin release.
Pulido O, BENCOSME S, de Bold M, de Bold A
Diabetologia. 1978; 15(3):197-204.
PMID: 359396
DOI: 10.1007/BF00421239.
Tryptophan and the control of plasma glucose concentrations in the rat.
Smith S, Pogson C
Biochem J. 1977; 168(3):495-506.
PMID: 147076
PMC: 1183797.
DOI: 10.1042/bj1680495.
